See also this year's filing and all EDGAR filings for this company.
PDF Report 0001044378_2023_Biocept_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | No stock price available | subcommand.plot | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001044378')"} |
Graph
Absolute values for 0001044378, Biocept INC
| xvar | xval | |
|---|---|---|
| 0 | IntangibleAssets | 0 |
| 1 | AssetsNonCurrent | 8,872,000 |
| 2 | AssetsCurrent | 16,343,000 |
| 3 | PropertyPlantAndEquipment | 2,572,000 |
| 4 | remainder_Assets | 3,086,000 |
| 5 | LongTermLiabilities | 9,175,000 |
| 6 | LiabilitiesCurrent | 5,506,000 |
| 7 | remainder_Liabilities | 7,332,000 |
| 8 | LaborExpense | 0 |
| 9 | CostOfGoodsAndServicesSold | 28,440,000 |
| 10 | GeneralAndAdministrativeExpense | 16,113,000 |
| 11 | GoodwillImpairmentLoss | 0 |
| 12 | OperatingCostsAndExpenses | 0 |
| 13 | DepreciationDepletionAndAmortization | 0 |
| 14 | SellingAndMarketingExpense | 7,127,000 |
| 15 | ResearchAndDevelopmentExpense | 6,161,000 |
| 16 | remainder_Expenses | -125,000 |
| 17 | remainder_Revenues | 25,858,000 |
| 18 | remainder_NetIncome | -229,000 |
| 19 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 30,873,000 |
| 1 | Liabilities | 22,013,000 |
| 2 | Expenses | 57,716,000 |
| 3 | Revenues | 25,858,000 |
| 4 | StockholdersEquity | 8,860,000 |
| 5 | NetIncome | -32,087,000 |
| 6 | ComprehensiveNetIncome | -32,087,000 |
| 7 | BaseVar | 68,344,500 |
| 8 | EconomicCapitalRatio | -0.282 |
Edgar->Model Mapping
Feature Distribution
Change over Time
